`
`Teva Pharm. v. Indivior, IPR2016-00280
`INDIVIOR EX. 2001 - 1/5
`
`
`
`Case 1:14-cv-01451-UNA Document 7 Filed 12/04/14 Page 2 of 2 PageID #: 181
`
`Teva Pharm. v. Indivior, IPR2016-00280
`INDIVIOR EX. 2001 - 2/5
`
`
`
`CM/ECF LIVE - U.S. District Court:ded
`
`Page 1 of 1
`
`Service of Process:
`1:14-cv-01451-UNA Reckitt
`Benckiser Pharmaceuticals Inc.
`et al v. Teva Pharmaceuticals
`USA Inc.
`
`PATENT
`
`U.S. District Court
`
`District of Delaware
`
`Notice of Electronic Filing
`
`The following transaction was entered by Bourke, Mary on 12/4/2014 at 12:01 PM EST and filed on
`12/4/2014
`Case Name:
`Case Number:
`Filer:
`
`Reckitt Benckiser Pharmaceuticals Inc. et al v. Teva Pharmaceuticals USA Inc.
`1:14-cv-01451-UNA
`Reckitt Benckiser Pharmaceuticals Inc.
`RB Pharmaceuticals Limited
`MonoSol Rx LLC
`Document Number:7
`
`Docket Text:
`SUMMONS Returned Executed by Reckitt Benckiser Pharmaceuticals Inc., RB
`Pharmaceuticals Limited, MonoSol Rx LLC. Teva Pharmaceuticals USA Inc. served
`on 12/3/2014, answer due 12/24/2014. (Bourke, Mary)
`
`1:14-cv-01451-UNA Notice has been electronically mailed to:
`
`Dana Kathryn Severance
`
`dseverance@wcsr.com, klytle@wcsr.com
`
`Mary W. Bourke mbourke@wcsr.com, dthomas@wcsr.com, kboots@wcsr.com,
`larcari@wcsr.com
`
`1:14-cv-01451-UNA Filer will deliver document by other means to:
`
`The following document(s) are associated with this transaction:
`
`Document description:Main Document
`Original filename:n/a
`Electronic document Stamp:
`[STAMP dcecfStamp_ID=1079733196 [Date=12/4/2014] [FileNumber=2390826-0
`] [44909e32e415fc67f4b20c8e82d82a1355dae999b060295a2a4c6cb769a8577970d
`a6d481e8e46b19eca23d8667b8be5ee02d289368516ddb0e4b456c2fcd3d8]]
`
`https://ecf.ded.uscourts.gov/cgi-bin/Dispatch.pl?590359436054992
`
`12/4/2014
`
`Teva Pharm. v. Indivior, IPR2016-00280
`INDIVIOR EX. 2001 - 3/5
`
`
`
`Thomas, Donna
`
`From:
`Sent:
`To:
`Subject:
`
`ded_nefreply@ded.uscourts.gov
`Thursday, December 04, 2014 12:01 PM
`ded_ecf@ded.uscourts.gov
`Activity in Case 1:14-cv-01451-UNA Reckitt Benckiser Pharmaceuticals Inc. et al v. Teva
`Pharmaceuticals USA Inc. Summons Returned Executed
`
`This is an automatic e-mail message generated by the CM/ECF system. Please DO NOT RESPOND to
`this e-mail because the mail box is unattended.
`***NOTE TO PUBLIC ACCESS USERS*** Judicial Conference of the United States policy permits
`attorneys of record and parties in a case (including pro se litigants) to receive one free electronic copy of
`all documents filed electronically, if receipt is required by law or directed by the filer. PACER access fees
`apply to all other users. To avoid later charges, download a copy of each document during this first
`viewing. However, if the referenced document is a transcript, the free copy and 30 page limit do not
`apply.
`
`U.S. District Court
`
`District of Delaware
`
`Notice of Electronic Filing
`
`The following transaction was entered by Bourke, Mary on 12/4/2014 at 12:01 PM EST and filed on 12/4/2014
`Reckitt Benckiser Pharmaceuticals Inc. et al v. Teva Pharmaceuticals USA Inc.
`Case Name:
`1:14-cv-01451-UNA
`Case Number:
`Reckitt Benckiser Pharmaceuticals Inc.
`Filer:
`RB Pharmaceuticals Limited
`MonoSol Rx LLC
`Document Number:7
`
`Docket Text:
`SUMMONS Returned Executed by Reckitt Benckiser Pharmaceuticals Inc., RB
`Pharmaceuticals Limited, MonoSol Rx LLC. Teva Pharmaceuticals USA Inc. served on
`12/3/2014, answer due 12/24/2014. (Bourke, Mary)
`
`1:14-cv-01451-UNA Notice has been electronically mailed to:
`
`Dana Kathryn Severance
`
`dseverance@wcsr.com, klytle@wcsr.com
`
`Mary W. Bourke mbourke@wcsr.com, dthomas@wcsr.com, kboots@wcsr.com, larcari@wcsr.com
`
`1:14-cv-01451-UNA Filer will deliver document by other means to:
`
`The following document(s) are associated with this transaction:
`
`Document description:Main Document
`Original filename:n/a
`
`1
`
`Teva Pharm. v. Indivior, IPR2016-00280
`INDIVIOR EX. 2001 - 4/5
`
`
`
`Electronic document Stamp:
`[STAMP dcecfStamp_ID=1079733196 [Date=12/4/2014] [FileNumber=2390826-0
`] [44909e32e415fc67f4b20c8e82d82a1355dae999b060295a2a4c6cb769a8577970d
`a6d481e8e46b19eca23d8667b8be5ee02d289368516ddb0e4b456c2fcd3d8]]
`
`2
`
`Teva Pharm. v. Indivior, IPR2016-00280
`INDIVIOR EX. 2001 - 5/5
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
